National autism wait-time investigation
The Middleman No One Invited to Dinner.
Canada is building a national dashboard to measure how long autistic children wait — and it stops the clock exactly where the expensive wait begins. The surest winner in the gap it leaves is the private layer in the middle.
The central truth
The number stops.The child does not.
Diagnosis was counted. Care was not.
Canada’s dashboard can measure the wait to diagnosis. Ontario families live a second, longer wait that no national number will capture: the wait for funded therapy.
One child. Two clocks.
Official clock
Referral → Diagnosis
Measured. Reported. Finished.Family clock
Diagnosis → First funded therapy
Unmeasured. Unreported. Still waiting.The argument in 30 seconds
One metric. Two missing waits.
Referral to assessment outcome, not time to funded service.
MCCSS FOI · Mar 2026; excludes children awaiting diagnosis.
Put time to funded therapy beside diagnostic wait on the same dashboard.
There is a national effort underway to fix something everyone agrees is broken: the time children wait for autism care. The National Child Autism Waitlist Initiative — NAWI, housed under the Autism Alliance of Canada — is standardizing how that wait gets measured across provinces, so the numbers can finally be compared, benchmarked, and reported on a public dashboard.1 On its own terms it sounds unarguable. You cannot fix what you do not measure.
But read what NAWI has decided to measure. In September 2024 the initiative convened clinical site leaders and a group of parents to define the key milestones — the “Date of Referral,” the “Wait Time” — and reached consensus on those definitions. Every one of them sits inside the diagnostic process: from the moment a child is referred to the moment a clinician confirms or rules out autism.1
That is one wait. It is real, and for many families it runs from several months to a couple of years. But it is not the wait that has made Ontario notorious.
The metric
Two waits, not one.
The first wait is the wait for a diagnosis — referral, to assessment, to verdict. The second begins the day the diagnosis is delivered: the wait for the funded therapy the diagnosis is supposed to unlock. In Ontario, that second wait is where children disappear. Of the 89,799 children registered in the Ontario Autism Program as of March 2026, just 20,633 — fewer than one in four — hold a funding agreement for services. The other 69,166 are waiting, many for more than five years.2
NAWI’s metric captures the first wait. It ends at diagnosis. The second wait — the years a diagnosed child spends with a binder full of paperwork and no therapist — falls entirely outside the number.
This is not a technicality. It is the whole game.
The wait a parent actually lives has three legs, not one:
- First concern → referral. The “wait and see,” the rounds of GP visits, the months it takes just to get onto a referral list. Often one to three years.
- Referral → diagnosis. The diagnostic assessment queue itself. Months to roughly two years.
- Diagnosis → funded therapy. In Ontario, the OAP core-funding wait. Five years or more.
NAWI’s clock starts at the second leg — the “Date of Referral” — and stops at the end of it, the day a diagnosis is confirmed. The first leg and the third, the two longest, both fall outside the window. This is not a matter of reading between the lines: NAWI’s own account concedes that the pre-referral period “is currently not captured,” and the entire metric is scoped to assessment and diagnosis.1The third leg — the funding wait — never enters the frame at all, because OAP funding is a post-diagnosis service and the clock has already stopped.
Put real durations on it. The structure below is documented; the specific years are an illustrative example, not NAWI’s own figures:
Exhibit 01 · The missing years
The lived wait has three legs. The dashboard counts one.
The most important wait is the one most likely to disappear from the national number.
Exhibit 02 · Where children are now
Only 23 of every 100 registered children hold an active agreement.
Fewer than one in four registered children hold an agreement for funded services.
Lived wait: about seven years. NAWI-reported wait: about twelve months. Nobody fabricated the twelve months — it is a real interval. It is simply not the wait.
And here is the part that survives a fact-checker: NAWI does not hide that it measures diagnostic wait — it says so plainly. The distortion is not in the fine print. It is in what happens when that number becomes the national wait-time figure on a public dashboard, with no competing national number standing beside it for the funding wait. “Autism wait time: twelve months” gets read by reporters, the public, and politicians as the wait for autism help — not the wait for an assessment. A dashboard built on time-to-diagnosis can show steady improvement — more clinics, faster assessments, shorter diagnostic queues — while the number of children waiting for actual therapy stays exactly where it is. And because the five-year funding leg has no standardized national metric of its own, it produces no benchmark, no line on the chart, no figure to quote. The number that would embarrass a government never gets generated, because the system was never asked to generate it.
A problem with no number is, politically, a problem that does not exist.
The consensus
Who agreed to the definition.
It matters who set the boundary. NAWI’s wait-time consensus was reached by diagnostic clinicians — the people whose work sits at the diagnostic stage.1
This is not an accusation; it is a structural fact with a predictable consequence. Ask the people who run the diagnostic bottleneck to define “the wait,” and you will get a definition that centers the diagnostic bottleneck. The metric validates the part of the system they can see and measure, and quietly excludes the part — funded treatment — that lives in a different budget, under a different ministry, with a far longer queue.
The convergence
The operator already inside the gate.
Accerta — through Accerta Services Inc. — leads the consortium that runs AccessOAP, the independent intake organization that is the front door to the Ontario Autism Program; its partners are Autism Ontario, McMaster University, and a care-coordination firm. It is, in other words, the operation that holds the database where the children wait. In 2023–24 that intake operation drew an estimated $57.9 million — the single largest non-therapy line in the program’s budget, in a year when less than half of all OAP spending reached the core clinical services children are waiting for.9
In October 2024, eleven days after the federal government launched its National Autism Strategy, Accerta amended its federal lobbying registration to add the Strategy as a subject matter. In 2025 it logged direct meetings with designated public office holders at Finance Canada and Veterans Affairs Canada. During the same stretch it added Government Procurement to its file, with stated intent to seek federal Requests for Proposals — its own words on the public record: it wants to compete for the contracts.3
For all the language of transformation and innovation, what Accerta actually does is administrative: it registers families, confirms eligibility, and tracks and reconciles the movement of money. Its consortium partners bring the autism expertise and the care coordination; Accerta brings the back office. In plain terms, it is an administrative back-office operator.
And in its most recent filing, that payment processor disclosed that it had applied to the federal AI Compute Access Fund — a $300-million program that awards between $100,000 and $5 million to help companies build and commercialize AI products — and that it wanted to engage federal decision-makers about its investment proposal.45The filing describes “an AI platform.” It does not, on its face, say the platform is about autism. But Accerta does not need the filing to say so. It already holds the national-scale autism intake data that any “national dashboard” would have to be built on top of.
Line the pieces up. NAWI is defining the national wait-time standard. A national standard implies a national platform to run it. Accerta already operates the largest autism intake system in the country, is lobbying on the national strategy, has told Ottawa in writing that it wants the procurements, and is seeking federal money to build an AI platform. Whether those threads were ever meant to meet is not something a filing can prove. That they are converging is simply what the public record shows.
The market that forms around a line
The connection shown is this article’s interpretation, not proof of a joint plan, contract, or coordination.
The summit
The policy machine in one room.
To see what the apparatus looks like when it is spending money, look at the Canadian Autism Leadership Summit. It is run by the Autism Alliance of Canada — the same organization that houses NAWI and its diagnostic-wait metric. In April 2026 it held its twelfth annual edition: sold out, three days, at the Fairmont Château Laurier, one of the grandest hotels in Ottawa.6
The theme was “Beyond the Now.” The language was “from strategy to action,” “accountability,” “systems change.” The headline event was a full day given over to an AI symposium — “AI and Autism: Innovation for Inclusion” — featuring major technology companies and startups pitching AI platforms to “reduce waitlist burden.”67 Around it: panels on system navigation, research posters, a leadership award, a federal public-health vice-president, senators, and a concurrent “Autism on the Hill” engagement on Parliament Hill.7
Exhibit 03 · Published program
One of three summit days was explicitly organized around AI.
- Responsible AI leadership dialogue
- Industry skill-building labs
- AI tools and real-world applications
- Rethinking system navigation
- Research posters and member showcase
- Parliamentary reception
- Community-driven system design
- Evidence to systems change
- Neuro-affirming care
One of three summit days was given over entirely to an AI symposium.
The summit also runs on corporate money, and it sells access by tier. The Alliance’s own sponsorship proposal offers “support” levels that have run from $5,000 for an entry “Bronze” session sponsor up to $25,000 and beyond for the lead “Platinum” supporter — the upper tiers buying logo placement across the Summit’s materials and, at the top, the chance to deliver welcoming or closing remarks from the stage.8This is, to be fair, how most non-profit conferences are funded. But it means a company can pay to put its brand on the country’s premier autism-policy gathering, and pay a little more to speak from its podium — at the same event where the proposed answer to the waitlist is, increasingly, a commercial AI platform.
Read that list again and notice what is missing from it: therapy money. The entire summit orbits the wait — nearly every session is, in some sense, about the wait — and yet its centre of gravity is conferencing, branding, leadership, and above all technology. The answer offered in the room is an AI platform, a data system, a navigation tool. Not a cheque to a provider so that a five-year-old can begin treatment this year instead of at eleven.
This is what managing the appearance of action looks like in practice: a sold-out summit at a grand hotel, themed on accountability, headlined by some of the largest technology companies in the world, convened by the very body that drew the wait-time metric so the funding wait produces no number — while the funding wait itself, the thing the whole gathering is organized around, continues exactly as before. The activity is real. The spend is real. The optics of action are real. The action is not.
Be precise about the charge. This is not to say the researchers, self-advocates, and families in the room are acting in bad faith; many are doing serious work, and convening has real value. The point is structural, and it is about proportion. When the most visible, best-funded, most photographed expression of a “waitlist crisis” is a three-day leadership summit with an AI symposium at the Château Laurier, the system has learned to perform concern at a level of polish it has never once brought to actually paying for care.
The gate
The layer between diagnosis and care.
Strip away the summit and the dashboard and look at the shape of the thing underneath. Between the government that funds autism therapy and the family that needs it, Ontario has inserted a private administrative layer — an intake contractor that registers children, determines their funding, and runs the gate. The question worth asking, plainly, is what that layer is for.
There is a respectable answer, and it deserves to be stated fairly. The case for letting private operators into a public service is value: that a contractor will run the thing faster, cheaper, or better than the state would manage on its own, and that the efficiency it adds is worth the margin it takes. That is the entire justification for market involvement in something like health care. If it holds, everyone gains — the public buys a better outcome than it could build for itself, and the operator earns its keep by delivering it.
So test the arrangement against its own justification. The outcome that matters is simple: a diagnosed child receiving funded therapy while the therapy can still do the most good. On that measure the wait has not shrunk — it averages more than five years, with 69,166 children registered and still unfunded.2 More money has gone in — the province raised the program budget to $965 million for 2026-27 — yet the share of registered children actually receiving funded services has barely moved in a year and a half, even as registrations keep climbing.2The deepest bottleneck is funding, and no amount of intake administration substitutes for it. But that is exactly the point: whatever value the private layer was supposed to add, it has not reached the place it was promised to reach — the time a child waits. The public is paying for a middleman whose central promise, faster access, remains undelivered.
Exhibit 04 · The administrative gate
The intermediary is funded to operate the path, not the therapy slot.
- Registration
- Queue oversight
- Funding agreement
- Reconciliation
Exhibit 05 · The stakeholder ledger
Who carries the wait?
Loses developmental time while waiting for a funding agreement.
RiskChildhood window closing.
Pays for both the therapy and the access machinery around it.
RiskFunding the gate as well as the care.
Owns the capped budget and the politics of the queue.
RiskPublic accountability.
Is paid to administer access while demand exceeds funded capacity.
RiskContract scrutiny.
Now follow the money through the arrangement and ask who, inside it, is actually better off. The family waits, and loses the one thing early intervention cannot replace: time. The taxpayer funds both the therapy budget and the apparatus built around it — paying, in effect, for the gate as well as for whatever is supposed to lie beyond it. The government spends, and absorbs the political damage of a wait it can no longer hide. And the intermediary is paid to administer the queue — its revenue attached to running the gate, not to getting children through it. On that ledger, the only party whose position improves no matter how long the wait lasts is the one in the middle.
This is the part that should land hardest: no one asked for that middle layer except the operators positioned to benefit from it. Families did not lobby to have a contractor inserted between them and their child's therapy. The public did not demand it. It is the middleman no one invited to dinner — and it is the only layer insulated from the wait. The pressure to entrench and expand the arrangement — to win the federal contracts, to build the national data platform, to position for the next procurement — comes, on the public record, from the operators themselves.3 The demand is shaped by the supplier-side market: a market talked into existence by the parties it benefits.
That is the test private medicine has to pass, and this arrangement fails it. A private layer earns its place by delivering value the public could not get otherwise. This one delivers a slower, more expensive, more elaborately managed version of the same wait — while drawing funding, data, and political attention toward itself and away from the children it exists to serve. When the layer in the middle is the only party whose position improves no matter how long the wait lasts, it is not private medicine working. It is administration presented as reform.
The test
When measurement becomes the product.
The apparatus for measuring the wait is becoming more elaborate, better-funded, and more authoritative than the effort to end it. A national initiative, a community dashboard, federal strategy meetings, an AI platform, a procurement pipeline — a growing enterprise organized around a number. And the number has been defined so that it can show progress without a single additional child receiving therapy. It is the most expensive, most sophisticated, and ultimately most useless kind of wait: the kind that is managed for how it looks rather than shortened for how long it is.
None of this requires bad faith from any individual. It requires only that everyone keep measuring the wait that is convenient and avoid the wait that is not. A diagnostic clinician measures the diagnostic queue. A government reports the metric that flatters it. A contractor builds the platform that runs it. Each step is reasonable. The sum is a polished, well-documented account of a problem that leaves the problem untouched.
Exhibit 06 · Dashboard versus reality
A public metric can improve while the therapy wait remains untouched.
Referral-to-diagnosis interval decreases.
Diagnosis delivered. Funded care still unavailable.
Exhibit 07 · What the dashboard should say
Put the visible metric beside the wait families are actually living.
Publish Referral → first funded service alongside Referral → diagnosis.
Show both waits on the national dashboard. One number hides the longer harm.
Hold every layer to the same test: does it move a child faster to funded therapy?
Childhood is a finite window. Metrics should protect it, not erase it.
The fix is one sentence long. Measure time to funded therapy — referral to the first dollar of service a child actually receives — not time to diagnosis. Publish that number, province by province, on the same dashboard. Until the metric counts the years a diagnosed child waits with nothing, the dashboard is not measuring the crisis.
It is managing the optics of it.
The public ask
Ask for the number that reaches care.
Ontario should publish, every quarter, the median and 90th-percentile time from referral to first funded autism service — beside diagnostic wait time. Not just referral to diagnosis. Not just registration counts. The number that matters is the one that follows a child all the way to funded care.
Write your MPP and ask for that metric on the public dashboard.
Source trail
Every solid line in the story.
- National Child Autism Waitlist Initiative.Autism Alliance of Canada’s project page describes the diagnostic scope, community dashboard, September 2024 consensus meeting, and the pre-referral period that is “currently not captured.” Open primary source
- Ontario Autism Program counts. MCCSS bi-weekly Core Clinical Services progress reports obtained through FOI release CSS2026-0749; canonical ETWO data updated to March 4, 2026. CBC published the January 2026 snapshot and the preceding 18-month trend. Open the data hub
- Accerta federal lobbying and AccessOAP role.ETWO’s source-linked record of registration amendments, communication reports, procurement language, and the AccessOAP consortium. Open the investigation
- Registry of Lobbyists. AccertaClaim Servicorp Inc., subject matter details, including the AI Compute Access Fund application and request to engage decision-makers about the proposal. Open federal registry
- AI Compute Access Fund.Innovation, Science and Economic Development Canada’s program page and guide: up to $300 million, with eligible project costs from $100,000 to $5 million. Open primary source
- CALS2026 announcement. Autism Alliance of Canada describes the sold-out April 14–16 summit at the Château Laurier and its full-day AI and Autism symposium. Open primary source
- CALS2026 published program. Session descriptions, speakers, member showcase, system-navigation panel, and parliamentary reception. Open primary source
- Historical CALS support proposal.Autism Alliance of Canada’s published 2023 corporate-support tiers and benefits. The article does not present them as current 2026 rates. Open the proposal
- AccessOAP allocation. The Trillium reported an estimated $57.9 million for AccessOAP in 2023–24 from ministry documents obtained through Freedom of Information. Open reporting
Fact versus analysis.Solid-line graphics summarize published records. Dashed-line graphics mark this article’s inference. Nothing here alleges improper lobbying, misuse of public funds, breach of contract, or a coordinated procurement plan by Accerta, Autism Alliance of Canada, AccessOAP, or their partners.
Corrections and right of reply.End The Wait Ontario invites any named party to respond. Material corrections are published under the site’s corrections policy.
Continue the record